Featured Speakers
Marion Abecassis
Senior Associate in Life Sciences
DLA PIPER
Sharri Adams-Edwards
Exec. Director, Clinical Operations
ADVERUM BIOTECHNOLOGIES
Angela Allen
Sr. Specialist, Global Site Agreements
MERCK
Kenneth Bachek
Head Clinical Site Agreements
ARGENX
Rachael Baker
Associate Director, Grants & Contracts
CELIDEX THERAPEUTICS
Janet Petrillo Ballantyne
Executive Director, Neuromuscular Clinical Trials Group
UNIVERSITY OF CALGARY
Nathan Beaver
Partner
FOLEY & LARDNER
Sherrie Bowen
Senior Contracting Analyst
SEATTLE CHILDREN'S RESEARCH INSTITUTE
Monica Chmielewski
Partner
FOLEY & LARDNER
Devin Cohen
Partner
ROPES & GRAY
Sean Cunningham
Director - Study Site Engagement Team Lead
TAKEDA
Kyle Faget
Partner
FOLEY & LARDNER
Gabrielle Field
Senior Associate, Global Regulatory
HOGAN LOVELLS
Lauren Goldsmith
Director of Site Budgets & Contracts
ARCUS BIOSCIENCES
Kate Hardey
Partner
KIRKLAND & ELLIS
Carolina Hewell
Director, Head of Country Operations
MERCK
Alison Hurd
Sr. Specialist, Global Site Agreements
MERCK
Adam Janoff
General Counsel and Head of Compliance
BIOLINERX
Jae Kim
Partner
DLA PIPER
Jason Lawn
Lead Counsel, Contracting and Adjunct Professor of Law
KYOWA KIRIN
Michelle Monosmith
Operations Administrator
MAYO CLINIC
Greg Montalbano
Associate General Counsel, Head of Compliance
ASSERTIO
Sarah Murry
Sr. Director, Clinical Contracts Counsel
ARCUS BIOSCIENCES
Leila Nosrat
Associate Director, Sr. Corporate Counsel of R&D
ALKERMES
Phillip Paone
Head of Site and Specialty Contracts
PFIZER
Jamie Peal
Contracts Attorney
MOFFITT CANCER CENTER
Tara Rabe
Operations Administrator, Legal Contract Administration
MAYO CLINIC
Eleana Rodriguez
Director Research Legal - Clinical Trial Agreements
UNIVERSITY HEALTH NETWORK
Jesselle Simeon
Director, Clinical Operations & Contracts Management
ADVERUM BIOTECHNOLOGIES
Peter Sullivan
Principal
SULLIVAN GROUP
Kara Titus
Senior Director, Procurement
DRAGONFLY THERAPEUTICS
Kim Veon
Sr. Specialist, Global Site Agreements
MERCK
Erin Williams
Senior Vice President, Regulatory & Study Startup
VELOCITY CLINICAL RESEARCH